The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response

Biological Chemistry

Volumn 380, Issue 3, 1999, Pages 293-297

  Kloetzel, Peter M ^a   Soza, Andrea ^a   Stohwasser, Ralf ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Antigen processing; PA28; Proteasome

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME;

ANTIGEN PRESENTATION; CELLULAR IMMUNITY; PRIORITY JOURNAL; REVIEW;

EID: 0033011162     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.040     Document Type: Review

References (43)

1. Aki, M., Shimbara, N., Takashina, M., Akiyama, K., Kagawa, S., Tamura, T., Tanahashi, N., Yoshimura, T., Tanaka, K., and Ichihara, A. (1994). Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J. Biochem. 115, 257-269.
2. Arnold, D., Driscoll, J., Androlewicz, M., Hughes, E., Cresswell, P., and Spies, T. (1993). Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules. Nature 360, 171-174.
3. Ahn, K., Erlander, M., Leturcq, D., Peterson, P.A., Früh, K., Yang, Y. (1996). In vivo characterisation of the proteasome regulator PA28. J. Biol. Chem. 271, 18237-18242.
4. Boes, B., Hengel, H., Ruppert, T., Multhaup, G., Koszinowski, U.H., and Kloetzel, P.M. (1994). Interferon-γ stimulation modulates the proteolytic activity and the cleavage site preference of 20S mouse proteasomes. J. Exp. Med. 179, 901-909.
5. Chen, Z., Hagler, J., Palombella, V.J., Melandri, F., Scherer, D., Ballard, D., and Maniatis, T. (1995). Signal-induced site-specific phosphorylation targets IkappaBalpha to the ubiquitin-proteasome pathway. Genes Dev. 13, 1586-1597.
6. Coux, O., Tanaka, K., and Goldberg, A.L. (1996). Structure and functions of the 20S and 26 S proteasomes. Annu. Rev. Biochem. 65, 801-847.
7. Dick, T.P., Ruppert, T., Groettrup, M., Kloetzel, P.M., Kuehn, L., Koszinowski, U.H., Stevanovic, S., Schild, H., and Rammensee, H.G. (1996). Coordinated dual cleavages by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86, 253-262.
8. Dubiel, W., Pratt, G., Ferrell, K., Rechsteiner, M. (1992). Purification of an 11S regulator of the multicatalytic proteinase. J. Biol. Chem. 267, 22369-22377.
9. Dubiel, W., Ferrell, K., and Rechsteiner, M. (1995). Subunits of the regulatory complex of the 26S protease. Mol. Biol. Rep. 21, 27-34.
10. Eggers, M., Boes-Fabian B., Ruppert, T., Kloetzel, P.M., and Koszinowski, U.H. (1995). The cleavage preference of the proteasome governs the yield of antigenic peptides. J. Exp. Med. 18, 1865-1870.
11. Fischer, M., Runkel, L., and Schaller, H. (1995). HBx protein of Hepatitis B virus interacts with the C-terminal protion of a novel human proteasome alpha subunit. Virus Genes 10, 99-102.
12. Griffin, T.A., Nandi, D., Cruz, M., Fehling, H.J., Van Kaer, L., Monaco, J.J., and Colbert, R.A. (1998). Immunoproteasome assembly: Cooperative incorporation of interferon-γ inducible subunits. J. Exp. Med. 187, 97-104.
13. Groettrup, M., Ruppert, T., Kuehn, L., Seeger, M., Standera, S., Koszinowski, U., and Kloetzel, P.M. (1995). The interferon-γ inducible 11S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20S proteasome in vitro. J. Biol. Chem. 270, 23808-23815.
14. Groettrup, M., Soza, A., Kuckelkorn, U., and Kloetzel, P.-M. (1996a). Peptide antigen production by the proteasome: complexity provides efficiency, Immunol. Today 17, 429-435.
15. Groettrup, M., Soza, A., Eggers, M., Kuehn, L., Dick, T.P., Schild, H., Rammensee, H.G., Koszinowski, U.H., and Kloetzel, P.M. (1996b). A role for the proteasome regulator PA28α in antigen presentation. Nature 381, 166-168.
16. Groettrup, M., Standera, S., Stohwasser, R., and Kloetzel, P.M. (1997). The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc. Natl. Acad. Sci. USA 94, 8970-8975.
17. Groll, M., Ditzel, L., Löwe, J., Atock, D.S., Bochtler, M., Bartunik, H.D., and Huber, R. (1997). Structure of 20 S proteasome from yeast at 2.4A resolution. Nature 386, 463-471.
18. Hendil, K.B., Khan, S., and Tanaka, K. (1998). Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes. Biochem J. 332, 749-754.
19. Hilt, W., and Wolf, D.H. (1996). Proteasomes: Destruction as a programme. Trends Biochem. Sci. 27, 96-102.
20. Hiller, M.M., Finger, A., Schweiger, M., and Wolf, D.H. (1996). ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science 273, 1725-1728.
21. Knowlton, J.R., Johnston, S.C., Whiteby, F.G., Realini, C., Zhang, Z., Rechsteiner, M., and Hill, C.P. (1997). Structure of the proteasome activator REGα (PA28α) Nature 390, 639-643.
22. Kominami, K., DeMartino, G.N., Moomaw, C.R., Slaughter, C.A., Shimbara, N., Fujimuro, M., Yokosawa, H., Hisamatsu, H., Tanahashi, N., Shimizu, Y., Tanaka, K., and Toh, E.A. (1995). Nin1p, a regulatory subunit of the 26S proteasome, is necessary for activation of Cdc28p kinase of Saccharomyces cerevisiae. EMBO J. 14, 3105-3115.
23. Kopp, F., Dahlmann, B., and Hendil, K.B. (1993). Evidence indicating that the human proteasome is a complex dimer. J. Mol. Biol. 229, 14-19.
24. Kuckelkorn, U., Frentzel, S., Kraft, R., Kostka, S., Groettrup, M., and Kloetzel, P.M. (1995). Incorporation of major histocompatibility complex - Encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-gamma. Eur. J. Immunol. 25, 2605-2611.
25. Kuehn, L., and Dahlmann, B. (1996). Reconstitution of proteasome activator PA28 from isolated subunits optimal activity is associated with an α,β-heteromultimer. FEBS Lett. 394, 183-186.
26. Lehner, P.J., and Cresswell, P. (1996). Processing and delivery of peptides presented by MHC class I molecules. Curr. Opin. Immunol. 8, 59-67.
27. Ma, C.P., Slaughter, C.A., and DeMartino, G.N. (1992). Identification, purification and characterization of a protein activator (PA28) of the 20S Proteasome (Macropain). J. Biol. Chem. 267, 10515-10523.
28. Musti, A.M., Treier, M., Peverali, F.A., and Bohmann, D. (1996). Differential regulation of c-Jun and Jun D by ubiquitin-dependent protein degradation. Biol. Chem. Hoppe-Seyler 377, 619-624.
29. Nandi, D., Woodward, E., Gindburg, D.B., and Monaco, J.J. (1997). Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor β subunits. EMBO J. 16, 101-113.
30. Realini, C., Dubiel, W., Pratt, G., Ferrell, K., and Rechsteiner, M. (1994). Molecular cloning and expression of a γ-interferon-inducible activator of the multicatalytic protease. J. Biol. Chem. 269, 20727-20732.
31. Realini, C., Jensen, C.C., Zhang, Z., Johnston, S.C., Knowlton, J.R., Hill, C.P., and Rechsteiner, M. (1997). Characterization of recombinant REGα, REGβ and REGγ proteasome activators. J. Biol. Chem. 272, 25483-25492.
32. Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A.L. (1994). Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761-771.
33. Rousset, R., Desbois, C., Bantignies, F., and Jalinot, P. (1996). Effects on NFkB1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome. Nature 381, 328-331.
34. Schmidt, M., and Kloetzel, P.M. (1997). Biogenesis of eukaryotic 20S proteasomes: the complex maturation pathway of a complex enzyme. FASEB J. 11, 1235-1243.
35. Schmidtke, G., Eggers, M., Ruppert, T., Groettrup, M., Koszinowski, U.H., and Kloetzel, P.M. (1998). Inactivation of a defined active site in the mouse 20S proteasome complex enhances major histocompatibility complex class I antigen presentation of a murine cytomegalovirus protein. J. Exp. Med. 187, 1641-1646.
36. Seeger, M., Ferrell, K., Frank, R., and Dubiel, W. (1997). HIV-1 Tat inhibits the 20S proteasome and its 11S regulator-mediated activation. J. Biol. Chem. 272, 8145-8148.
37. Shimbara, N., Nakajima, H., Tanahashi, N., Ogawa, K., Niwa, S., Uenaka, A., Nakayama, E., and Tanaka, K. (1997). Double cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region. Genes Cells 2, 785-800.
38. Sibille, C., Gould, K.G., Willardgallo, K., Thomson, S., Rivett, A.J., Powis, S., Butcher, G.W., and Debaetselier, P. (1995). Lmp2(+) proteasomes are required for the presentation of specific antigens to cytotoxic t lymphocytes. Current Biology 5, 923-930.
39. Song, X.L., Mott, J.D., Von Kampen, J., Pramanik, B., Tanaka, K., Slaughter, C.A., and DeMartino, G.N. (1996). A model for the quaternary structure of the proteasome activator PA28. J. Biol. Chem. 271, 26410-26417.
40. Song, X., von Kampen, J., Slaughter, C.A., and DeMartino, G.N., (1997). Relative functions of the α and β subunits of the proteasome activator PA28. J. Biol. Chem. 272, 27994-28000.
41. Soza, A., Knuehl, C., Groettrup, M., Henklein, P., Tanaka, K., and Kloetzel, P.-M. (1997). Expression and subcellular localization of mouse 20S proteasome activator complex PA28. FEBS Lett. 473, 27-34.
42. Theobald, M., Ruppert, T., Kuckelkorn, U., Hernandez, J., Hussler, A., Ferreira, E.A., Liewer, U., Biggs, J., Levine, A.J., Huber, C., Koszinowski, U.H., Kloetzel, P.M., and Sherman, L.A. (1998).The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope. J. Exp. Med. 188, 1017-1028.
43. Yang, Y., Fruh, K., Ahn, K., and Peterson, P.A. (1995). In vivo assembly of the proteasomal complexes, implications for antigen processing. J. Biol. Chem. 270, 27687-27694.